These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9741911)
21. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells. Tijerina M; Kopecková P; Kopecek J Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627 [TBL] [Abstract][Full Text] [Related]
22. Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigens. Jelínková M; Strohalm J; Plocová D; Subr V; St'astný M; Ulbrich K; Ríhová B J Control Release; 1998 Mar; 52(3):253-70. PubMed ID: 9743446 [TBL] [Abstract][Full Text] [Related]
23. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Tijerina M; Fowers KD; Kopecková P; Kopecek J Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494 [TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics of polymer-bound adriamycin. Seymour LW; Ulbrich K; Strohalm J; Kopecek J; Duncan R Biochem Pharmacol; 1990 Mar; 39(6):1125-31. PubMed ID: 2322298 [TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026 [TBL] [Abstract][Full Text] [Related]
26. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135 [TBL] [Abstract][Full Text] [Related]
27. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657 [TBL] [Abstract][Full Text] [Related]
28. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation. Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189 [TBL] [Abstract][Full Text] [Related]
29. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin. Seib FP; Jones AT; Duncan R J Drug Target; 2006 Jul; 14(6):375-90. PubMed ID: 17092838 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates. Flanagan PA; Kopecková P; Kopecek J; Duncan R Biochim Biophys Acta; 1989 Oct; 993(1):83-91. PubMed ID: 2804126 [TBL] [Abstract][Full Text] [Related]
31. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy. Pan H; Sima M; Yang J; Kopeček J Macromol Biosci; 2013 Feb; 13(2):155-60. PubMed ID: 23339052 [TBL] [Abstract][Full Text] [Related]
34. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
35. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy. Etrych T; Mrkvan T; Ríhová B; Ulbrich K J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976 [TBL] [Abstract][Full Text] [Related]
36. Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers. Machová D; Koziolová E; Chytil P; Venclíková K; Etrych T; Janoušková O Eur J Pharm Biopharm; 2018 Oct; 131():141-150. PubMed ID: 30075311 [TBL] [Abstract][Full Text] [Related]
37. Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells. David A; Kopecková P; Rubinstein A; Kopecek J Bioconjug Chem; 2001; 12(6):890-9. PubMed ID: 11716678 [TBL] [Abstract][Full Text] [Related]
38. Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates. Paul A; Vicent MJ; Duncan R Biomacromolecules; 2007 May; 8(5):1573-9. PubMed ID: 17419585 [TBL] [Abstract][Full Text] [Related]
39. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946 [TBL] [Abstract][Full Text] [Related]
40. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences. Ríhová B; Strohalm J; Hovorka O; Subr V; Etrych T; Chytil P; Pola R; Plocová D; Boucek J; Ulbrich K J Control Release; 2008 Apr; 127(2):110-20. PubMed ID: 18325618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]